Agenda - Day 2

There are no agenda items with this track

10:00 am

10:00 am

Networking

Networking

Enter Networking Lounge, Connect with Your Industry Colleagues

  • Get a good start on the day and make connections with industry leadership
  • Join “drop-in” roundtables on most topical issues
  • Schedule 1-2-1 video meetings with peers
  • Gather essential content at virtual exhibit booths

11:00 am

11:00 am

Setting Today’s Plan from your Host

Gather your learning take-aways and key highlights of this event to map the current situation and help in achieving success from today’s event.

11:05 am

11:05 am

Panel Discussion

Adapt Your Strategy to an Uncertain Marketplace and Succeed in Securing Public Payer PLA’s

Getting products listed for reimbursement with public payers can be challenging in a transitional, uncertain market.  Get the insight you need to meet the expectations of INESSS and the pCPA to navigate your new product through their submission processes.  Walk away with an action plan for your public PLA submission strategy by:

  • Understanding the types of products provinces need
  • Reviewing your value proposition to be sure it meets INESSS and pCPA expectations
  • Gaining valuable insight on any changes on the horizon for public PLA submission requirements

Position your company to succeed in an uncertain environment with a solid public PLA strategy

11:40 am

11:40 am

Panel Discussion

Elevate Your Submission Strategy for PLA’s with Private Payers

Continued tightening of access to private payor formularies combined with a move to outsource benefit plan and administration to third parties for some payers, means more barriers to access this market than before.  Hone your private payor access strategy by understanding new market developments and payor priorities.  Create an action plan to:

  • Leverage elements of successful public PLA submissions and adapt them for the private payer market
  • Analyze the influence of public payer decisions on private payors to increase your preparedness
  • What pharma companies can do to optimize the ROI of their submissions to private payers

Gain insight into what private payers need and succeed with a tailored approach to securing a PLA

12:20 pm

12:20 pm

Networking

Networking

Build Relationships, Network and Experience Unparalleled Peer-to-Peer Learning

Expand your network and engage in-depth learning with your peers. Take advantage of any format to further build your knowledge and networking base:

  • “Drop-in” virtual Roundtable chats with up to 15 fellow delegates
  • Cozy 3-4 person discussion
  • Engage in 1:1 video conversation with peers or vendors
  • Vendor solution roundtables

12:50 pm

12:50 pm

Case Study

Benefit Plan Performance; Advance Your Market Access Plans with Insights on Plan Sponsors’ Demands for Sustainability

The increased scrutiny plan sponsors are applying before including medications on their formularies is also now being applied to plan performance.  Heighten your awareness of how plan sponsors intend to achieve sustainability.  Adapt your market access strategy by:

  • Understanding why sponsors are increasingly turning to third-parties to analyze their spending
  • Gaining insights into where plan sponsors have uncovered the greatest inefficiencies
  • How the use of more granular data will drive plan design in the future

Give your market access strategy an edge with insights on new plan performance analysis.

1:10 pm

1:10 pm

Networking

Networking

Visit Virtual Booths, Source Content and Engage in Demos with Industry Experts

  • Pose your biggest questions to leading industry vendor experts through 1:1 video conversations or chat.
  • Experience a live demo and understand your options. Source leading-edge content from virtual booths.
  • Walk away satisfied with solutions to your biggest challenges.

1:40 pm

1:40 pm

Panel Discussion

The Patient perspective – Instil the Patients’ Voice into Your Market Access Strategy to Enhance Your Product’s Success

Involving patient groups has become a cornerstone to the success of new product launches.  Advance the validity of your R&D results, RWE and your market access strategy by incorporating the patient voice from the earliest possible stage of development.  Create a blueprint to:

  • Initiate greater collaboration with patient groups earlier on to engage them within the boundaries of compliance
  • Understand the benefits of involving patients in the trial design stage
  • Gain early insight into how patients react to your product that can enhance your success throughout your development cycle, submission processes and beyond to patient support

Instil the patients’ voice into your R&D to advance your market access strategy

2:20 pm

2:20 pm

Key Take-Aways and Summary of Day Two from your Host

Hear the key solutions and take-aways from today’s sessions. Source a summary of actions points for you to implement. Learn about the key highlights and content for tomorrow.

2:30 pm

2:30 pm

Networking

Networking

Networking Extravaganza and Virtual Happy Hour!

  • Meet informally with fellow delegates in “Drop-in” virtual roundtable chats.
  • Engage in 1:1 video conversation with peers or vendors.
  • Connect with fellow delegates as “recommend matches” based on similar interests and business objectives.

3:00 pm

3:00 pm

Conference Day 2 Adjourns

Get the latest news

*Privacy Policy